You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of participants

From: Development and validation of a prediction model for the risk of citrate accumulation in critically ill patients with citrate anticoagulation for continuous renal replacement therapy: a retrospective cohort study based on MIMIC-IV database

Variables

Total

(n = 1083)

Training set

(n = 618)

Internal validation set(n = 265)

External validation set(n = 200)

P- value

Gender, n(%)

Ā Ā Ā Ā 

0.700

Female

412 (38.0%)

240 (38.8%)

240 (38.8%)

71 (35.5%)

Ā 

Male

671 (62.0%)

378 (61.2%)

378 (61.2%)

129 (64.5%)

Ā 

Age, years, median[IQR]

65.0 [54.5;74.0]

65.0 [54.0;75.0]

65.0 [54.0;75.0]

66.0 [56.0;75.0]

0.716

Weight, kg, median[IQR]

88.4 [73.2;104]

88.8 [73.6;104]

88.8 [73.6;104]

90.0 [74.8;108]

0.219

Height, cm, median[IQR]

170 [161;178]

170 [162;178]

170 [162;178]

170 [162;178]

0.767

Sepsis, n(%)

Ā Ā Ā Ā 

0.456

No

84 (7.76%)

53 (8.58%)

53 (8.58%)

12 (6.00%)

Ā 

Yes

999 (92.2%)

565 (91.4%)

565 (91.4%)

188 (94.0%)

Ā 

Shock, n(%)

Ā Ā Ā Ā 

0.636

No

101 (9.33%)

57 (9.22%)

57 (9.22%)

16 (8.00%)

Ā 

Yes

982 (90.7%)

561 (90.8%)

561 (90.8%)

184 (92.0%)

Ā 

Hepatic Insufficiency, n(%)

Ā Ā Ā Ā 

0.989

No

658 (60.8%)

375 (60.7%)

375 (60.7%)

121 (60.5%)

Ā 

Yes

425 (39.2%)

243 (39.3%)

243 (39.3%)

79 (39.5%)

Ā 

Mechanical Ventilation, n(%)

Ā Ā Ā Ā 

0.66

No

304 (28.1%)

168 (27.2%)

168 (27.2%)

56 (28.0%)

Ā 

Yes

779 (71.9%)

450 (72.8%)

450 (72.8%)

144 (72.0%)

Ā 

CVVH, n(%)

Ā Ā Ā Ā 

0.788

No

1031 (95.2%)

586 (94.8%)

586 (94.8%)

191 (95.5%)

Ā 

Yes

52 (4.80%)

32 (5.18%)

32 (5.18%)

9 (4.50%)

Ā 

CVVHD, n(%)

Ā Ā Ā Ā 

0.843

No

1060 (97.9%)

606 (98.1%)

606 (98.1%)

195 (97.5%)

Ā 

Yes

23 (2.12%)

12 (1.94%)

12 (1.94%)

5 (2.50%)

Ā 

CVVHDF, n(%)

Ā Ā Ā Ā 

0.93

No

75 (6.93%)

44 (7.12%)

44 (7.12%)

14 (7.00%)

Ā 

Yes

1008 (93.1%)

574 (92.9%)

574 (92.9%)

186 (93.0%)

Ā 

Diabetes, n(%)

Ā Ā Ā Ā 

0.591

No

649 (59.9%)

368 (59.5%)

368 (59.5%)

126 (63.0%)

Ā 

Yes

434 (40.1%)

250 (40.5%)

250 (40.5%)

74 (37.0%)

Ā 

Aki, n(%)

Ā Ā Ā Ā 

0.516

No

157 (14.5%)

83 (13.4%)

83 (13.4%)

32 (16.0%)

Ā 

Yes

926 (85.5%)

535 (86.6%)

535 (86.6%)

168 (84.0%)

Ā 

Crrt_parameter, ml/h, median[IQR]

Ā Ā Ā Ā Ā 

Blood_flow

120.00 [120.00;150.00]

120.00 [120.00;150.00]

120.00 [120.00;150.00]

120.00 [120.00;150.00]

0.561

Citrate

180.00 [180.00;200.00]

180.00 [180.00;200.00]

180.00 [180.00;200.00]

180.00 [180.00;200.00]

0.787

Dialysate Rate

700 [500;1000]

700 [500;1000]

700 [500;1000]

800 [500;1000]

0.627

Postfilter Replacement Rate

200 [200;200]

200 [200;200]

200 [200;200]

200 [200;200]

0.382

Prefilter Replacement Rate

1500 [1200;1800]

1600 [1200;1800]

1600 [1200;1800]

1500 [1200;1800]

0.228

Replacement Rate

1600 [1400;2000]

1700 [1400;2000]

1700 [1400;2000]

1650 [1400;2000]

0.349

Vital_signs, median[IQR]

Ā Ā Ā Ā Ā 

Map, mmHg

70.0 [58.0;84.0]

70.0 [58.0;83.0]

70.0 [58.0;83.0]

69.0 [56.0;82.2]

0.305

HR, bmp

95.0 [80.5;110]

95.5 [82.0;112]

95.5 [82.0;112]

94.0 [81.8;110]

0.147

Spo2,%

97.0 [93.0;100]

97.0 [93.0;100]

97.0 [93.0;100]

96.0 [93.0;99.0]

0.13

Laboratory test, median[IQR]

Ā Ā Ā Ā Ā 

Wbc, k/ul

12.7 [8.20;18.7]

12.6 [8.22;18.5]

12.6 [8.22;18.5]

12.8 [8.43;19.8]

0.921

RR, insp/min

21.0 [16.0;25.0]

21.0 [16.0;25.0]

21.0 [16.0;25.0]

21.0 [16.0;25.2]

0.634

Plt, k/lu

154 [90.0;235]

156 [90.2;235]

156 [90.2;235]

158 [95.0;250]

0.244

Hgb, mg/dl

9.50 [8.00;11.3]

9.50 [8.00;11.3]

9.50 [8.00;11.3]

9.50 [8.20;11.1]

0.979

Hct,%

29.5 [25.0;35.2]

29.4 [25.1;35.3]

29.4 [25.1;35.3]

29.0 [24.8;34.7]

0.962

Albumin, mg/dl

2.80 [2.30;3.26]

2.80 [2.30;3.30]

2.80 [2.30;3.30]

2.80 [2.40;3.20]

0.953

Calciumtotal, mmol/L

8.10 [7.60;8.80]

8.10 [7.60;8.80]

8.10 [7.60;8.80]

8.10 [7.70;8.80]

0.831

PH

7.32 [7.22;7.39]

7.32 [7.23;7.39]

7.32 [7.23;7.39]

7.31 [7.22;7.38]

0.59

Po2,mmHg

82.0 [50.0;152]

81.0 [50.0;154]

81.0 [50.0;154]

81.5 [49.0;142]

0.928

Co2,mmHg

40.0 [34.0;48.0]

40.0 [34.0;48.0]

40.0 [34.0;48.0]

41.0 [35.8;49.0]

0.698

Lac, mmol/L

2.40 [1.50;4.30]

2.40 [1.50;4.38]

2.40 [1.50;4.38]

2.25 [1.50;3.73]

0.662

PT, sec

17.1 [13.8;23.2]

17.0 [13.8;23.5]

17.0 [13.8;23.5]

16.5 [14.1;21.7]

0.908

APTT, sec

36.5 [30.2;48.3]

36.5 [29.6;48.0]

36.5 [29.6;48.0]

35.6 [30.3;49.2]

0.799

Anion_Gap, mmol/L

18.0 [15.0;23.0]

18.0 [15.0;23.0]

18.0 [15.0;23.0]

18.0 [15.0;22.2]

0.87

Tbil, umol/L

1.00 [0.50;3.45]

1.10 [0.50;3.38]

1.10 [0.50;3.38]

1.00 [0.50;3.10]

0.971

Alt, u/L

34.0 [17.0;125]

35.0 [17.0;120]

35.0 [17.0;120]

29.5 [17.0;103]

0.686

Ast, u/L

75.0 [33.0;246]

74.5 [33.0;241]

74.5 [33.0;241]

69.0 [33.8;232]

0.56

Metformin, n(%)

Ā Ā Ā Ā 

0.219

No

1077 (99.4%)

616 (99.7%)

616 (99.7%)

199 (99.5%)

Ā 

Yes

6 (0.55%)

2 (0.32%)

2 (0.32%)

1 (0.50%)

Ā 

Erythromycin, n(%)

Ā Ā Ā Ā 

0.744

No

1063 (98.2%)

607 (98.2%)

607 (98.2%)

195 (97.5%)

Ā 

Yes

20 (1.85%)

11 (1.78%)

11 (1.78%)

5 (2.50%)

Ā 

Vis Score

14.0 [5.00;27.0]

13.0 [5.00;27.8]

13.0 [5.00;27.8]

14.0 [5.00;26.0]

0.998

Apssiii

77.0 [63.0;94.0]

78.0 [64.0;94.0]

78.0 [64.0;94.0]

78.0 [63.0;92.2]

0.137

Hosp Day, d,median[IQR]

19.5 [9.92;33.7]

19.5 [9.66;33.5]

19.5 [9.66;33.5]

21.2 [10.9;34.8]

0.535

Icu Day, d,median[IQR]

9.59 [5.05;17.3]

9.51 [4.96;17.0]

9.51 [4.96;17.0]

9.94 [5.65;18.0]

0.685

Is Icu Dead, n(%)

Ā Ā Ā Ā 

0.832

No

601 (55.5%)

338 (54.8%)

338 (54.8%)

114 (57.0%)

Ā 

Yes

481 (44.5%)

279 (45.2%)

279 (45.2%)

86 (43.0%)

Ā 

Is Hosp Dead, n(%)

Ā Ā Ā Ā 

0.969

No

536 (49.5%)

304 (49.3%)

304 (49.3%)

99 (49.5%)

Ā 

Yes

546 (50.5%)

313 (50.7%)

313 (50.7%)

101 (50.5%)

Ā 

Death Within Hosp 28days, n(%)

Ā Ā Ā Ā 

0.926

No

602 (55.6%)

344 (55.8%)

344 (55.8%)

113 (56.5%)

Ā 

Yes

480 (44.4%)

273 (44.2%)

273 (44.2%)

87 (43.5%)

Ā 

Death Within Icu 28days, n(%)

Ā Ā Ā Ā 

0.705

No

558 (51.6%)

321 (52.0%)

321 (52.0%)

106 (53.0%)

Ā 

Yes

524 (48.4%)

296 (48.0%)

296 (48.0%)

94 (47.0%)

Ā 

Citrate_accumulation, n(%)

Ā Ā Ā Ā 

0.95

No

961 (88.7%)

550 (89.0%)

550 (89.0%)

177 (88.5%)

Ā 

Yes

122 (11.3%)

68 (11.0%)

68 (11.0%)

23 (11.5%)

Ā 
  1. AKI, Chronic kidney disease (CKD), TMP(Transmembrane pressure), Mean arterial pressure (MAP), Oxygen saturation (SpO2), White blood cells (WBC), Hemoglobin (Hgb), Platelets (PLT), Hematocrit (HCT), Serum albumin, Total bilirubin (TBIL), Aspartate aminotransferase(AST), PH, Oxygen partial pressure (PaO2), Carbon dioxide partial pressure (PaCO2), Lactate (Lac), Prothrombin time (PT), Activated partial thromboplastin time (APTT), Vasoactive-inotropic score (VIS), and Acute Physiology Score III (APSIII)